Midcareer Investigator Award in Patient-Oriented NeuroAIDS Research
以患者为导向的神经艾滋病研究中职业生涯调查员奖
基本信息
- 批准号:8774931
- 负责人:
- 金额:$ 18.26万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-12-07 至 2015-11-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAffectAnti-Retroviral AgentsAppointmentAreaAwardBiological AssayBiological MarkersBrainChronic DiseaseClinical ResearchClinical Research Curriculum AwardClinical TrialsCollaborationsContinuing EducationCytomegalovirusDataDevelopmentDiagnosisDiagnosticDiseaseDoctor of MedicineDrug InteractionsDrug KineticsEducationEducation ProjectsEducational process of instructingEquipmentEventFacultyFellowshipFibroblast Growth FactorFundingGoalsGrantHIVHIV-associated neurocognitive disorderHepatitis C virusIndividualInfectionInfluentialsInstitutional National Research Service AwardInternationalJunior PhysicianK-Series Research Career ProgramsLaboratoriesLeadLeadershipLifeLightMeasurementMeasuresMedical StudentsMedicineMentorsMethodsMid-Career Clinical Scientist Award (K24)ModelingNational Institute of Mental HealthNebraskaNervous system structureNeurocognitiveNeurologicOutcomePerformancePharmaceutical PreparationsPharmacologyPlasmaPlasmodiumPopulationPostdoctoral FellowPrognostic MarkerProteinsRegimenResearchResearch InstituteResearch MethodologyResearch PersonnelResearch Project GrantsResourcesRisk FactorsRoleScientistSecureTimeToxoplasmaTrainingTranslational ResearchWagesWorkaddictionantimicrobialantiretroviral therapycareerco-infectioncostdesigndrug distributiongraduate studentinstrumentinterdisciplinary approachinterestlongitudinal analysisnervous system disorderneuroAIDSneurocognitive disorderneurofilamentoutcome forecastpathogenpatient orientedpatient oriented researchprofessorpublic health relevancescreeningskillssuccessyoung adult
项目摘要
DESCRIPTION (provided by applicant): Scott Letendre, M.D. is an Associate Professor of Medicine at UCSD and former K23 Career Development Award recipient. In the past decade, Dr. Letendre has led or collaborated on many publicly and privately funded translational research projects. His influential work has focused on the risk factors and treatment of HIV-associated neurocognitive disorder (HAND) in the US and international settings. During this period, he has also mentored more than 30 trainees in patient-oriented research, including graduate and medical students, post-doctoral researchers, and junior faculty. In the proposed K24 mid-career investigator award, Dr. Letendre will expand his mentoring of junior investigators and will focus his mentoring and his own research on three main objectives. Antiretroviral treatment of the nervous system: Dr. Letendre will mentor trainees on design and performance of HAND clinical trials and CSF pharmacology projects, particularly focusing on longitudinal projects that measure all drugs in an antiretroviral regimen to better understand how drug interactions and time influence virologic and neurocognitive outcomes. Biomarker correlates of disease and treatment: Dr. Letendre will mentor trainees on measurement and analysis of biomarker data with the goal of developing a clinically useful panel for screening, diagnosis, and prognosis of HAND. This work will be supported by new equipment purchased with funds from a recent S10 Shared Instrument Grant. Coinfections in HIV-infected individuals: Dr. Letendre will work with trainees on projects that evaluate the impact on the nervous system of latent or minimally symptomatic infections with pathogens such as Plasmodium, Cytomegalovirus, Toxoplasma, and hepatitis C virus. This work will particularly focus on Dr. Letendre's existing work in international settings. Dr. Letendre will mentor trainees using a multidisciplinary approach that includes regular direct engagement, participation in R25, T32, and K30 programs at UCSD, active participation in existing research projects, support for new research projects, and networking with other investigators. Dr. Letendre will also obtain training in mentoring and analysis of longitudinal data. In summary, this K24 award will secure protected time for Dr. Letendre to mentor trainees in neuroAIDS methods, including the responsible conduct of patient- oriented research. Dr. Letendre will coordinate his efforts with other UCSD resources, including the R25- funded "International Research Fellowship in NeuroAIDS", the T32-funded "Training in Research on Addictions in Interdisciplinary NeuroAIDS", and the CTSA-funded "Clinical and Translational Research Institute".
描述(由申请人提供):医学博士Scott Letendre是UCSD医学副教授和前K23职业发展奖获得者。在过去的十年中,Letendre博士领导或合作了许多公共和私人资助的翻译研究项目。他的有影响力的工作集中在美国和国际环境中与艾滋病毒相关的神经认知障碍(手)的治疗。在此期间,他还指导了30多名以患者为导向的研究,包括研究生和医学生,博士后研究人员和初级教师。在拟议的K24中级调查员奖中,Letendre博士将扩大对初级调查人员的指导,并将将他的指导和自己的研究集中在三个主要目标上。神经系统的抗逆转录病毒治疗:Letendre博士将指导受训者有关手动临床试验和CSF药理学项目的设计和性能,特别是专注于纵向项目,这些纵向项目测量了抗逆转录病毒方案中的所有药物,以更好地了解药物相互作用和时间影响病毒学性和神经认知能力。生物标志物的疾病和治疗相关性:Letendre博士将指导学员对生物标志物数据进行测量和分析,以开发一个临床上有用的小组,以筛查,诊断和预后。这项工作将由最近的S10共享工具赠款购买的新设备提供支持。 HIV感染者的共同感染:Letendre博士将与受训者合作,以评估对病原体(例如疟原虫,巨细胞病毒,毒素,毒质量和肝炎)病原体的潜在或微小症状感染的影响。这项工作将特别关注Letendre博士在国际环境中的现有工作。 Letendre博士将使用多学科的学员指导受训者,其中包括定期直接参与,参与UCSD的R25,T32和K30计划,积极参与现有研究项目,对新研究项目的支持以及与其他研究人员进行网络。 Letendre博士还将获得纵向数据指导和分析的培训。总而言之,该K24奖将为Letendre博士提供受保护的时间,以指导受训者的神经辅助方法,包括负责患者的研究。 Letendre博士将与其他UCSD资源进行协调,包括R25资助的“国际神经辅助研究奖学金”,T32资助的“跨学科神经辅助研究成瘾研究培训”以及CTSA资助的“临床和转化研究所”。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Scott L Letendre其他文献
Scott L Letendre的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Scott L Letendre', 18)}}的其他基金
Aging, Polypharmacy and Neurotoxicity in Adults Living with HIV
成人艾滋病毒感染者的衰老、多药治疗和神经毒性
- 批准号:
10577736 - 财政年份:2020
- 资助金额:
$ 18.26万 - 项目类别:
Aging, Polypharmacy and Neurotoxicity in Adults Living with HIV
成人艾滋病毒感染者的衰老、多药治疗和神经毒性
- 批准号:
10374038 - 财政年份:2020
- 资助金额:
$ 18.26万 - 项目类别:
Aging, Polypharmacy and Neurotoxicity in Adults Living with HIV
成人艾滋病毒感染者的衰老、多药治疗和神经毒性
- 批准号:
10013739 - 财政年份:2020
- 资助金额:
$ 18.26万 - 项目类别:
Measurement of ART Drug Concentrations in Brain by 19F-MRS as an Indicator of Neurotoxicity
通过 19F-MRS 测量脑内 ART 药物浓度作为神经毒性指标
- 批准号:
10023281 - 财政年份:2019
- 资助金额:
$ 18.26万 - 项目类别:
Measurement of ART Drug Concentrations in Brain by 19F-MRS as an Indicator of Neurotoxicity
通过 19F-MRS 测量脑内 ART 药物浓度作为神经毒性指标
- 批准号:
9925549 - 财政年份:2019
- 资助金额:
$ 18.26万 - 项目类别:
Sustained Training in Aging and HIV Research (STAHR)
老龄化和艾滋病毒研究持续培训(STAHR)
- 批准号:
10483564 - 财政年份:2016
- 资助金额:
$ 18.26万 - 项目类别:
Sustained Training in Aging and HIV Research (STAHR)
老龄化和艾滋病毒研究持续培训(STAHR)
- 批准号:
10615240 - 财政年份:2016
- 资助金额:
$ 18.26万 - 项目类别:
Midcareer Investigator Award in Patient-Oriented NeuroAIDS Research
以患者为导向的神经艾滋病研究中职业生涯调查员奖
- 批准号:
8466639 - 财政年份:2012
- 资助金额:
$ 18.26万 - 项目类别:
Midcareer Investigator Award in Patient-Oriented NeuroAIDS Research
以患者为导向的神经艾滋病研究中职业生涯调查员奖
- 批准号:
8594262 - 财政年份:2012
- 资助金额:
$ 18.26万 - 项目类别:
Midcareer Investigator Award in Patient-Oriented NeuroAIDS Research
以患者为导向的神经艾滋病研究中职业生涯调查员奖
- 批准号:
8968863 - 财政年份:2012
- 资助金额:
$ 18.26万 - 项目类别:
相似国自然基金
海洋缺氧对持久性有机污染物入海后降解行为的影响
- 批准号:42377396
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
氮磷的可获得性对拟柱孢藻水华毒性的影响和调控机制
- 批准号:32371616
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
还原条件下铜基催化剂表面供-受电子作用表征及其对CO2电催化反应的影响
- 批准号:22379027
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
CCT2分泌与内吞的机制及其对毒性蛋白聚集体传递的影响
- 批准号:32300624
- 批准年份:2023
- 资助金额:10 万元
- 项目类别:青年科学基金项目
在轨扰动影响下空间燃料电池系统的流动沸腾传质机理与抗扰控制研究
- 批准号:52377215
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Inter-CFAR Women and HIV Biennial Symposium
Inter-CFAR 妇女与艾滋病毒双年研讨会
- 批准号:
10762305 - 财政年份:2023
- 资助金额:
$ 18.26万 - 项目类别:
Reducing Stigma in People Who Inject Drugs with HIV Using a Rapid Start Antiretroviral Therapy Intervention
使用快速启动抗逆转录病毒治疗干预措施减少艾滋病毒注射者的耻辱
- 批准号:
10756389 - 财政年份:2023
- 资助金额:
$ 18.26万 - 项目类别:
Influence of fetal antiretroviral exposure on gut microbiota, systemic inflammation and neurodevelopment in infants exposed to HIV
胎儿抗逆转录病毒暴露对暴露于 HIV 的婴儿的肠道微生物群、全身炎症和神经发育的影响
- 批准号:
10617395 - 财政年份:2023
- 资助金额:
$ 18.26万 - 项目类别:
ADELANTE: A Randomized Controlled Trial of an Intervention to Improve Engagement in Care for Latinos with HIV
ADELANTE:一项旨在提高拉丁裔艾滋病毒感染者护理参与度的干预措施的随机对照试验
- 批准号:
10757099 - 财政年份:2023
- 资助金额:
$ 18.26万 - 项目类别:
Early prevention interventions towards ART-free pediatric HIV remission
早期预防干预措施以实现免抗逆转录病毒疗法儿童艾滋病毒缓解
- 批准号:
10700531 - 财政年份:2023
- 资助金额:
$ 18.26万 - 项目类别: